A 2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Author： Bibbiani F. Oh J.D. Petzer J.P. Castagnoli N. Chen J.-F. Schwarzschild M.A. Chase T.N.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.184, Iss.1, 2003-11, pp. : 285-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

By Calon F. Rajput A.H. Hornykiewicz O. Bedard P.J. Di Paolo T.

Neurobiology of Disease, Vol. 14, Iss. 3, 2003-12 ,pp. : 404-416

Elsevier

Access to resources Recommend Favorite

Motor neurone disease and animal models

By Price D.L. Cleveland D.W. Koliatsos V.E.

Neurobiology of Disease, Vol. 1, Iss. 1, 1994-11 ,pp. : 3-11

Academic Press

Access to resources Recommend Favorite

Animal models of Parkinson’s disease progression

By Meredith Gloria Sonsalla Patricia Chesselet Marie-Francoise

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 385-398

Springer Publishing Company

Access to resources Recommend Favorite

Antiparkinsonian Action of a Opioid Agonist in Rodent and Primate Models of Parkinson's Disease

By Hille C.J. Fox S.H. Maneuf Y.P. Crossman A.R. Brotchie J.M.

Experimental Neurology, Vol. 172, Iss. 1, 2001-11 ,pp. : 189-198

Elsevier

Access to resources Recommend Favorite

The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D 2 , but Not D 1 , Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease

By Maneuf Y.P. Crossman A.R. Brotchie J.M.

Experimental Neurology, Vol. 148, Iss. 1, 1997-11 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite